The In Vitro Diagnostics Ivd Market is covered by Business Market Insights with 2025 as the base year and 2026–2033 as the forecast period. The In Vitro Diagnostics (IVD) Market size was valued at US$ 80.68 billion in 2025 and is projected to reach US$ 143.54 billion by 2033, registering a CAGR of 7.47% during 2026–2033.
Senior management should treat the market as a...
The global next generation sequencing market is increasingly shaped by how vendors combine hardware, consumables, and analytics into complete offerings. Valued at USD 11.74 billion in 2025, the market is projected to reach USD 13.14 billion in 2026 and USD 34.47 billion by 2034, growing at a CAGR of 12.8% during the forecast period 2026–2034. Key players include Illumina Inc., Thermo...
Global Lab-on-a-Chip Market Set to Surpass USD 16.37 Billion Driven by Decentralized Point-of-Care Diagnostics, Microfluidic Drug Discovery, and Organ-on-Chip Breakthroughs
The international life sciences, clinical diagnostics, and biotechnology ecosystems are undergoing an architectural transition toward micro-scale operational integration. According to an extensive industry evaluation...
According to the latest report published by Data Bridge Market Research, the IVD In Cardiology and Neurology Market
The global IVD in cardiology and neurology market size was valued at USD 18.45 billion in 2024 and is expected to reach USD 39.37 billion by 2032, at a CAGR of 9.94% during the forecast period.
To impart a supreme quality to this...
According to the latest report published by Data Bridge Market Research, the Needle Free Blood Drawing Devices Market
The global Needle free blood drawing devices market size was valued at USD 576.55 billion in 2025 and is expected to reach USD 1226.92 billion by 2033, at a CAGR of 9.90% during the forecast period
This Needle Free Blood Drawing Devices...
According to the latest report published by Data Bridge Market Research, the Fluorescent Antibody Test (FAT) Market
The global fluorescent antibody test (FAT) market size was valued at USD 2.50 billion in 2025 and is expected to reach USD 4.39 billion by 2033, at a CAGR of 7.30% during the forecast period
For generating the Fluorescent Antibody Test...